Life Sciences Archives - Page 6 of 17 - Becker's Hospital Review

Drug company to cut 65% of staff | Flu, COVID vaccines get fast-track status | Study links Ozempic to vision loss | FDA recalls 230K bottles of antidepressant

December 18, 2024 BHR Newsletter 1. FDA grants fast-track status to combination mRNA flu and COVID-19 vaccine candidates Full story 2. Eli Lilly, telehealth firm team up to expand Zepbound access Full story 3. Massachusetts drug company to cut 65%…

Zepbound beats out Wegovy in study | The race to create an oral GLP-1 drug | Walgreens eyes private equity sale | 20 drugs now in shortage

December 11, 2024 BHR Newsletter 1. Zepbound outperforms Wegovy for weight loss: Study Full story 2. The race to create an oral GLP-1 obesity drug: 4 things to know Full story 3. Walgreens eyes private equity sale: WSJ report Full…

Ozempic is getting cheaper | Sanofi adds $600M plant | 6 GLP-1 study findings to know | Forbes honors '30 Under 30' in healthcare

December 4, 2024 BHR Newsletter 1. Sanofi adds new $600M manufacturing plant Full story 2. Ozempic is becoming cheaper Full story 3. Forbes honors '30 Under 30' in healthcare for 2025 Full story 4. 400 health systems gather to boost…

Controversial drug trial halted | RFK on Ozempic | 1st gene therapy delivered into brain approved | Biden proposes Medicare coverage for weight loss drugs

November 27, 2024 BHR Newsletter 1. RFK Jr.'s comments on Ozempic: What to know Full story 2. Controversial Alzheimer's drug trial halted Full story 3. Biden administration proposes Medicare coverage for weight loss drugs: 10 things to know Full story…

Mounjaro lowers diabetes risk | FDA rejects liver disease drug | 53% of adults are eligible for Ozempic | Trump taps Dr. Oz for CMS lead

November 20, 2024 BHR Newsletter 1. FDA rejects full approval of liver disease drug Full story 2. Mounjaro lowers Type 2 diabetes risk in phase 3 trial: Study Full story 3. President-elect Trump taps Dr. Oz for CMS administrator: 10…

COVID-Flu vaccine trial advances | Warning added to Ozempic, Mounjaro labels | FDA could pull decongestant | UnitedHealth sued over Amedisys deal

November 13, 2024 BHR Newsletter 1. FDA adds warning to Ozempic, Mounjaro and other GLP-1 labels Full story 2. FDA lifts clinical hold on combined COVID-19-influenza vaccine trials Full story 3. J&J sues government over 340B rebate plan Full story…

Trump wins election: 7 notes | Ozempic, Wegovy shortages fixes | Patient dies in gene-therapy trial | US drugmakers to cut reliance on China

November 6, 2024 BHR Newsletter 1. 2 drug companies to pay $49M in alleged inflation scheme Full story 2. Ozempic, Wegovy shortages resolved: FDA Full story 3. Trump wins election: 7 notes for healthcare leaders Full story 4. Up to…

Trump, Harris on drug prices | FDA recalls antidepressant bottles | Alzheimer's drug trials raise ethical concerns | 9 drugs in shortage

October 30, 2024 BHR Newsletter 1. FDA recalls 7,000 antidepressant bottles Full story 2. Alzheimer's drug trials raise ethical concerns over risk disclosure Full story 3. Where Trump, Harris stand on prescription drug prices: 6 notes Full story 4. Transform…

FDA rethinks Mounjaro shortage | Flu-COVID drug study paused | CVS workers go on strike | Walmart starts prescription deliveries

October 23, 2024 BHR Newsletter 1. FDA retreats from declaring end to Mounjaro shortage Full story 2. Combination flu-COVID drug study paused after 'serious adverse event' Full story 3. Walmart is 1st retailer to deliver Rx, general products together Full…

FDA reconsiders Mounjaro ban | 1st COVID-flu combo test approved | GSK settles lawsuits fo $2.2B | Walgreens to close 1,200 stores

October 16, 2024 BHR Newsletter 1. GSK agrees to settle 80,000 Zantac lawsuits for $2.2B Full story 2. FDA to reconsider decision barring sale of compounded Mounjaro: 5 things to know Full story 3. Walgreens to close 1,200 stores: 6…